Association between matrix metalloproteinase 9 polymorphisms and breast cancer risk: An updated meta-analysis and trial sequential analysis

被引:8
|
作者
Xu, Tai [1 ,2 ]
Zhang, Siming [1 ]
Qiu, Dongqin [1 ]
Li, Xiaoyuan [1 ]
Fan, Yuanlin [1 ]
机构
[1] Meizhou Peoples Hosp, Dept Breast Surg, 63 Huangtang Rd, Meizhou 514000, Guangdong, Peoples R China
[2] Meizhou Peoples Hosp, Guangdong Prov Key Lab Precis Med & Clin Translat, Meizhou 514000, Guangdong, Peoples R China
关键词
Breast cancer; Matrix metalloproteinase 9; Polymorphism; Meta-analysis; MATRIX METALLOPROTEINASES; GENETIC POLYMORPHISMS; PROMOTER REGIONS; GELATINASE-B; MMP-9; STATISTICS; EXPRESSION; SUSCEPTIBILITY; PROGRESSION; SURVIVAL;
D O I
10.1016/j.gene.2020.144972
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Numerous studies have sought associations between matrix metalloproteinase 9 (MMP-9) polymorphisms and breast cancer risk. However, these studies have yielded conflicting results. Hence, we performed an updated meta-analysis to clarify the effects of four MMP-9 gene polymorphisms (rs3918242, rs2250889, rs3787268, and rs17576) on breast cancer risk. Methods: A comprehensive literature search for eligible studies was conducted in five electronic databases, including PubMed, Embase and Web of Science, up to March 1, 2020. Summary odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of associations in random-effects models. For the reduction of type I errors, a trial sequential analysis (TSA) was performed. Results: Twenty-one studies (8813 breast cancer cases and 9323 controls) were included in the quantitative analysis. For rs3918242, the overall ORs were significant under allelic comparison (OR (A vs. G) = 1.34; 95% CI 1.03, 1.74, P = 0.028) and the recessive genetic model (OR (AA vs. GG+GA) = 1.40; 95% CI 1.06, 1.84, P = 0.016). For rs2250889, the ORs were significant under homozygote comparison (OR (GG vs. CC) = 2.57; 95% CI 1.22, 5.42, P = 0.013), heterozygote comparison (OR (GC vs. CC) = 2.48; 95% CI 1.17, 5.23, P = 0.018), and the dominant genetic model (OR (GG+GC vs. CC) = 2.53; 95% CI 1.23, 5.20, P = 0.012). No associations were observed for rs3787268 or rs17576. The subgroup analyses indicated that the risk effect of the rs3918242 A allele was observed only among Asians. TSA showed that the findings for rs3918242, rs3787268, and rs17576 were robust, but many more patients are needed before definitive conclusions can be made for rs2250889. Conclusion: Our meta-analysis suggests that MMP-9 rs3918242, but not rs3787268 and rs17576 polymorphisms, may be risk factors for breast cancer. The effect of rs2250889 needs further confirmation with a larger sample size.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Meta-Analysis of Association Between BRIP1 Polymorphisms and Breast Cancer Risk
    Dianatpour, Ali
    Faramarzi, Sepideh
    Ghafouri-Fard, Soudeh
    [J]. INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2019, 12 (01)
  • [22] Association between ATM polymorphisms and cancer risk: a meta-analysis
    Shen, Li
    Yin, Zhi-Hua
    Wan, Yan
    Zhang, Yue
    Li, Kun
    Zhou, Bao-Sen
    [J]. MOLECULAR BIOLOGY REPORTS, 2012, 39 (05) : 5719 - 5725
  • [23] The association between two polymorphisms in the TYMS gene and breast cancer risk: a meta-analysis
    Wang, Jun
    Wang, Baocheng
    Bi, Jingwang
    Di, Jianshi
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (01) : 203 - 209
  • [24] The association between two polymorphisms in the TYMS gene and breast cancer risk: a meta-analysis
    Jun Wang
    Baocheng Wang
    Jingwang Bi
    Jianshi Di
    [J]. Breast Cancer Research and Treatment, 2011, 128 : 203 - 209
  • [25] Association Between Matrix Metalloproteinase Family Gene Polymorphisms and Ischemic Stroke: a Meta-analysis
    Wen, Dan
    Du, Xin
    Nie, Shao-Ping
    Dong, Jian-Zeng
    Ma, Chang-Sheng
    [J]. MOLECULAR NEUROBIOLOGY, 2014, 50 (03) : 979 - 985
  • [26] Association Between Matrix Metalloproteinase Family Gene Polymorphisms and Ischemic Stroke: a Meta-analysis
    Dan Wen
    Xin Du
    Shao-Ping Nie
    Jian-Zeng Dong
    Chang-Sheng Ma
    [J]. Molecular Neurobiology, 2014, 50 : 979 - 985
  • [27] Association of N-acetyltransferase 1 polymorphism and bladder cancer risk: an updated meta-analysis and trial sequential analysis
    Xu, Zicheng
    Li, Xiao
    Qin, Zhiqiang
    Xue, Jianxin
    Wang, Jingyuan
    Liu, Zhentao
    Cai, Hongzhou
    Yu, Bin
    Xu, Ting
    Zou, Qin
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2017, 32 (03): : E297 - E304
  • [28] Matrix metalloproteinase 9 and prostate cancer risk: a meta-analysis of 1059 participants
    Fuling, M. A.
    Wang, Zhun
    Abdularab, Abdulalam
    Dai, Liang
    Niu, Yuanjie
    Jiang, Ning
    [J]. MINERVA UROLOGICA E NEFROLOGICA, 2017, 69 (04) : 324 - 329
  • [29] ASSOCIATION BETWEEN MATRIX METALLOPROTEINASE FAMILY GENE POLYMORPHISMS AND RISK OF ISCHEMIC STROKE: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Talwar, P.
    Misra, S.
    Pandit, A. K.
    Kumar, A.
    Kumar, P.
    Sagar, R.
    Prasad, K.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 61 - 61
  • [30] Association between matrix metalloproteinases polymorphisms and ovarian cancer risk: A meta-analysis and systematic review
    Zhu, Xu-Ming
    Sun, Wei-Feng
    [J]. PLOS ONE, 2017, 12 (09):